De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Yu GuHaoran ZhengShengwei MoTao GuoLihua ChenJunjun YangYang XiangPublished in: BMC women's health (2023)
For patients with isolated MS, treatment by chemotherapy and surgery are radical procedure, and initial treatment using chemotherapy alone should be considered for MS with synchronous intramedullary AML. Poor response to chemotherapy, short interval to leukemia occurrence, and heavy tumor burden (> 10 cm) could indicate a poor prognosis for patients with MS.
Keyphrases
- poor prognosis
- mass spectrometry
- multiple sclerosis
- acute myeloid leukemia
- ms ms
- long non coding rna
- minimally invasive
- newly diagnosed
- end stage renal disease
- locally advanced
- risk assessment
- prognostic factors
- chronic kidney disease
- immune response
- combination therapy
- risk factors
- acute coronary syndrome
- rectal cancer
- patient reported
- replacement therapy